Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation treatment protocol for prior SU011248 participants
2004-001093-11Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sunitinib in Nonhematologic neoplasms, sponsored by Pfizer. Started Feb 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on 2004-001093-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001093-11.